The development of effective anti-androgen therapies for prostate cancer is a major scientific advance.
Most men with prostate cancer won’t die from the disease.
An old military tactic, widely used in Roman and medieval times, is now being put to good use in cancer research.
In an ongoing clinical trial, researchers are using gold nanoparticles to target prostate cancer cells. So far, the results are promising, and side effects are relatively minimal.
The men of TODAY team up to push prostate exams in new PSA: ‘Get checked!’...